Pharmaceutical Profile
Pharmaceutical

@Pharmaceutical

Followers
27K
Following
2
Media
8K
Statuses
56K

Everything pharma.

Joined April 2008
Don't wanna be here? Send us removal request.
@Pharmaceutical
Pharmaceutical
1 year
Medication Mistakes Pharmacists Want You to Stop Making https://t.co/MqlasH1a0N
2
1
6
@Pharmaceutical
Pharmaceutical
1 year
Psychedelics May Give the Living a Glimpse Into Near-Death States https://t.co/SvMqUIORUu
3
1
5
@Pharmaceutical
Pharmaceutical
1 year
Kamala Harris Can Tout Success at Lowering Drug Prices https://t.co/mlZmf2IOTy
0
1
2
@Pharmaceutical
Pharmaceutical
1 year
Who Should Take Paxlovid for Covid-19? https://t.co/tcTI3kah0U
1
1
4
@Pharmaceutical
Pharmaceutical
1 year
A New Treatment for Severe Allergic Reactions — Without the Needle https://t.co/4VxWVY6ovm
2
1
4
@Pharmaceutical
Pharmaceutical
1 year
¿Quienes deben tomar Paxlovid? https://t.co/27BNbL4RYi
0
1
1
@Pharmaceutical
Pharmaceutical
1 year
Kamala Harris Outlines Her Plan for an ‘Opportunity Economy’ https://t.co/2MBlp72DDe
0
2
1
@Pharmaceutical
Pharmaceutical
1 year
Acuerdan baja de precios para 10 medicamentos caros y comunes en EE. UU. https://t.co/lwtqu2o9AI
1
1
2
@Pharmaceutical
Pharmaceutical
1 year
Biden and Harris Announce Deal to Lower Drug Prices https://t.co/NYHvvKbsh1
0
1
1
@Pharmaceutical
Pharmaceutical
1 year
As Harris and Biden Take a Victory Lap on Drug Costs, She Sets the Pace https://t.co/cf5HTSx5Ty
0
1
1
@Pharmaceutical
Pharmaceutical
1 year
U.S. Unveils Price Limits for 10 Costly or Common Medications https://t.co/FuCQJxulTx
0
1
0
@Pharmaceutical
Pharmaceutical
1 year
2026 Prices for Drugs That Are Subject to Negotiations https://t.co/2lvcMYLVdn
0
0
0
@Pharmaceutical
Pharmaceutical
1 year
AstraZeneca’s Calquence Aces Phase III CLL Trial, Eyes Fixed-Duration Approval https://t.co/tdSuuxxlsF
0
1
1
@Pharmaceutical
Pharmaceutical
1 year
Ventyx Ends Development of TYK2 Inhibitor After Phase II Flop in Crohn’s Disease https://t.co/u8uCtyQSHZ
0
2
1
@Pharmaceutical
Pharmaceutical
1 year
Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline https://t.co/Ex01ly8Noj
0
0
1
@Pharmaceutical
Pharmaceutical
1 year
WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms https://t.co/ewnncilLHE
0
2
1
@Pharmaceutical
Pharmaceutical
1 year
FDA Flags Safety Risks of Compounded Versions of Novo’s Semaglutide, Reports Hospitalizations https://t.co/qcy9O8Z7vk
0
2
3
@Pharmaceutical
Pharmaceutical
1 year
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff https://t.co/FaPad0jRA4
0
1
1
@Pharmaceutical
Pharmaceutical
1 year
Merck’s Keytruda in Combo With Padcev Granted CHMP Positive Opinion in Urothelial Carcinoma https://t.co/1fmvhlM6VJ
0
0
1
@Pharmaceutical
Pharmaceutical
1 year
New York Has Only 1 Drug Stockpiled in Case of a Bird Flu Epidemic https://t.co/v5TvEZn8eh
0
0
2